Bevacizumab gamma 7.5mg/0.3ml solution for injection vials
- SNOMED code
44750011000001100- Active compound
- Bevacizumab gamma
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 0.3 ml, vial
- Ingredients
- Bevacizumab gamma
— 25 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninjection.intravitreal
Solution for injection, Intravitreal - Controlled drug
- No Controlled Drug Status
Products
Lytenava 7.5mg/0.3ml solution for injection vials (Outlook Therapeutics Inc)
Lytenava 7.5mg/0.3ml solution for injection vials
- SNOMED code
44741911000001105- Supplier
- Outlook Therapeutics Inc
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravitreal
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Lytenava 7.5mg/0.3ml solution for injection vials (Outlook Therapeutics Inc) 1 vial44742011000001103 ref. pack | 💯 Available Legal category: POM | 00382491000012 | NHS Indicative Price £470 | • Hospital |
| — |
Reference packs
Bevacizumab gamma 7.5mg/0.3ml solution for injection vials 1 vial
- SNOMED code
44741811000001100- Quantity and unit
- 1 vial
- Packs